Effectiveness and safety analysis of switching to tenofovir alafenamide after entecavir or tenofovir treatment

被引：0
|
作者：
Liu, Xue [1 ]
Zhao, Zhihao [1 ]
Kong, Xianggen [2 ]
Cui, Shiyu [2 ]
Jiang, Xuemei [2 ]
机构：
[1] Shandong Univ, Jinan, Peoples R China
[2] Shandong Publ Hlth Clin Ctr, Jinan, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
WED-415
引用
收藏
页码：S804 / S805
页数：2
相关论文
共 50 条
  • [11] COST-EFFECTIVENESS OF SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE TO TENOFOVIR ALAFENAMIDE VS. ENTECAVIR FOR CHRONIC HEPATITIS B PATIENTS IN GREECE
    Sinakos, E.
    Kachru, N.
    Tsoulas, C.
    Jeyakumar, S.
    Smith, N.
    Yehoshua, A.
    Cholongitas, E.
    VALUE IN HEALTH, 2023, 26 (06) : S82 - S83
  • [12] Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
    Hye Yeon Chon
    Sang Hoon Ahn
    Yoon Jun Kim
    Jung-Hwan Yoon
    Jeong-Hoon Lee
    Dong Hyun Sinn
    Seung Up Kim
    Hepatology International, 2021, 15 : 1328 - 1336
  • [13] Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
    Chon, Hye Yeon
    Ahn, Sang Hoon
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, Jeong-Hoon
    Sinn, Dong Hyun
    Kim, Seung Up
    HEPATOLOGY INTERNATIONAL, 2021, 15 (06) : 1328 - 1336
  • [14] SAFETY AND EFFICACY OF SWITCHING ENTECAVIR TO TENOFOVIR VERSUS TENOFOVIR TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B: A COMPARATIVE STUDY
    Ungtrakul, Teerapat
    Dechma, Jiraporn
    Chunnuan, Pitchayachuda
    Kusuman, Pattama
    Pothijaroen, Charinthip
    Tawpa, Jantarika
    Pongpun, Wanwisa
    Soonklang, Kamonwan
    Sriprayoon, Tassanee
    Tanwandee, Tawesak
    GASTROENTEROLOGY, 2018, 154 (06) : S1135 - S1135
  • [15] EFFECTIVENESS AND SAFETY OF SWITCHING TENOFOVIR DISOPROXIL FUMARATE AND ENTECAVIR TO TENOFOVIR ALAFENAMIDE FUMARATE ( TAF) IN VIROLOGICALLY SUPPRESSED CHRONIC HEPATITIS B VIRUSINFECTED PATIENTS WITH ONEMINUTE OSTEOPOROSIS RISK TEST
    Li, Hui
    Li, Chunmei
    Wei, Jia
    Liu, Yunhua
    Gong, Ming
    Zhang, Ruyi
    Geng, Jiawei
    Wang, Hongyan
    Yu, Zhijian
    Wang, Zi
    Liu, Xiang
    HEPATOLOGY, 2023, 78 : S513 - S513
  • [16] Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real-world multicenter cohort study
    Shin, Hyunjae
    Kim, Seung Up
    Song, Byeong Geun
    Park, Youngsu
    Ko, Yunmi
    Park, Jeayeon
    Hur, Moon Haeng
    Lee, Yun Bin
    Cho, Eun Ju
    Lee, Jeong-Hoon
    Yu, Su Jong
    Yoon, Jung-Hwan
    Sinn, Dong Hyun
    Kim, Yoon Jun
    HEPATOLOGY RESEARCH, 2024, 54 (07) : 627 - 637
  • [17] Risk of hepatocellular carcinoma after curative treatment when switching from Tenofovir Disoproxil Fumarate or Entecavir to Tenofovir Alafenamide: a real-world multicenter cohort study
    Shin, Hyunjae
    Ko, Yunmi
    Park, Youngsu
    Kim, Yoon Jun
    JOURNAL OF HEPATOLOGY, 2024, 80 : S798 - S798
  • [18] Coformulated bictegravir, emtricitabine, tenofovir alafenamide after initial treatment with bictegravir or dolutegravir and emtricitabine/tenofovir alafenamide
    Sax, Paul E.
    DeJesus, Edwin
    Crofoot, Gordon
    Ward, Douglas
    Benson, Paul
    Dretler, Robin
    Mills, Anthony
    Brinson, Cynthia
    Wei, Xuelian
    Collins, Sean E.
    Cheng, Andrew
    AIDS, 2018, 32 (12) : 1723 - 1725
  • [19] Improvement of hepatic fibrosis after tenofovir disoproxil fumarate switching to tenofovir alafenamide for three years
    Huynh, Tung
    Bui, Delana MyAn
    Zhou, Tina Xiwen
    Hu, Ke-Qin
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (07)
  • [20] Safety and Effectiveness of Tenofovir Alafenamide in the Turkish Population: A Systematic Review
    Tabak, Fehmi
    Yapali, Suna
    Celen, Mustafa K.
    Guner, Rahmet
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2023, 29 (02): : 43 - 51
12345